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▪ Introduction
▪ Vascular complications in infective endocarditis
▪ Ischemic stroke
▪ Hemorrhage
▪ Mycotic aneurysm
▪ Management
▪ Surgical indications
▪ Impact of neurological complication on patient management
▪ 27 yo F with history of IVDA presents with acute onset right sided weakness , 
numbness and facial droop.
▪ She is febrile and tachycardic 
▪ Blood works showed elevated WBC.
▪ CT chest abdomen pelvis showed splenic infarcts and necrotic lesions in lungs 
bilaterally.
▪ Infective endocarditis (IE) is an uncommon 
infectious disease with an annual incidence 
ranging from 3 to 7 per 100 000 person-years.
▪ IE is characterized by increased morbidity and 
mortality
▪ Third or fourth most common life-threatening 
infection syndrome, after sepsis, pneumonia, and 
intra-abdominal abscess.
* Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381:628]. 
Lancet. 2012;380:2197– 2223. doi: 10.1016/S0140-6736(12)61689-4..

▪ Symptomatic neurological complications occur in 15–30%. They are mainly embolism 
from vegetations.
▪ Neurological manifestations occur before or at IE diagnosis in a majority of cases, but 
new or recurrent events can also take place later in the course of IE
▪ 7% can present with septic emboli as presenting sign for IE
Merrill C. Kanter and Robert G. Hart First published July 1, 1991, DOI: https://doi.org/10.1212/WNL.41.7.1015, Clinical presentation, etiology, and 
outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 
2009;169:463–473
. Neurological Complications of Infective Endocarditis Risk Factors, Outcome, and Impact of Cardiac Surgery: A Multicenter Observational Study
▪ Most common manifestation of IE
▪ Clinically in 20-40% patient with IE and additional 30% with asymptomatic lesions 
Mechanism Likely embolism
▪ 65% of embolic events in IE involve the CNS, and 40-60% of CNS emboli lodge in the 
distribution of the middle cerebral artery.
Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers, Brain MRI Findings in Neurologically Asymptomatic 
Patients with Infective Endocarditis
Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med. 2000;160:2781–2787, Neurological Outcome of Septic Cardioembolic Stroke After
Infec
Clinical characteristics and thrombolytic outcomes of infective endocarditis-associated stroke.
Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy.

Cho SM et al.Cerebral microbleeds predict infectious intracranial aneurysm in infective endocarditis.
Hess A  Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. AJNR 
Am J Neuroradiol. 2013 Aug;34(8):1579-84 
▪ Update in history: Patient was 
seen last time normal 2 hours 
ago.
Thrombolysis for Ischemic Stroke Associated With Infective Endocarditis Results From the Nationwide Inpatient Sample Ganesh Asaithambi Stroke. 2013;44:2917–2919
Morris, Nicholas A et al. “Neurologic complications in infective endocarditis: identification, management, and impact on cardiac surgery.” The Neurohospitalist vol. 4,4 (2014): 213-22. 
doi:10.1177/1941874414537077

THROMBECTOMY 
IN IE
Prevent further neurological 
complications or deteriorations.
Decrease risk of embolization.
▪ Systemic embolization in 22% to 50% of cases of IE. Most commonly brain and spleen. 
▪ The highest incidence of embolic complications is seen with:
▪ Mitral valve with particular micro-organisms (S. aureus, S. bovis, Candida)
▪ Size and mobility of the vegetations : Vegetation >10 mm in length. Higher risk in patients with 
larger (>15 mm) and mobile vegetations.
▪ The risk of new events (occurring after initiation of antibiotic therapy) is 6– 21%.
Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort
** The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 200
▪ The primary goal of antibiotic treatment is to 
eradicate infection and sterilizing vegetation.
▪ Challenges include:
▪ Focal infection with high bacterial density
▪ Slow rate of bacterial growth
▪ Low microorganism metabolic activity
▪ Host immunity
▪ Drugs pharmacokinetics and dynamics
Am Heart J. 2007 Dec;154(6):1086-94. Epub 2007 Sep 12.
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in 
infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS).
Dickerman SA
A study from the ICE group demonstrated that the incidence 
of stroke in patients receiving appropriate antimicrobial 
therapy was 4.8/1000 patient-days in the first week of 
therapy, falling by 65% to 1.7/1000 patient-days in the 
second week, and further thereafter.

A randomized trial compared oral 
aspirin 325 mg/d with placebo in 
115 IE patients. No significant 
benefit was observed in aspirin-
treated patients in terms of 
vegetation resolution and embolic 
events. Moreover, there was a trend 
toward more bleeding episodes in 
the aspirin-treated patients. A 
randomized trial of aspirin on 
the risk of embolic events in 
patients with infective 
endocarditis.
All patients with prosthetic valve IE due 
to S aureus with mechanical prostheses 
were undergoing oral anticoagulant 
therapy, while no patient with native 
valve IE due to S aureus was undergoing 
such treatment. Therefore, it seems 
clinically plausible that anticoagulant 
therapy played a deleterious effect on 
the neurologic complications
Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J. Infective endocarditis due to 
Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med. 1999;159:473–475
▪ While in hospital patient worsens and has 
new focal neurologic deficits.
▪ A day prior she was deemed candidate for 
valve replacement surgery. 
▪ Incidence vary from 4%-27%.
▪ ICH in IE related to bleeding into infarcts, rupture of a vessel wall affected by 
septic arteritis, or rupture of a mycotic aneurysm
Neurologic complications of endocarditis: a 12-year experience.Salgado
Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study.Sonneville
Mechanisms of Intracranial Hemorrhage in Infective Endocarditis Hart 1987
• Septic embolization to the arterial 
vasa vasorum or the intraluminal 
space
• Prevalence is 2% to 4%, amounting 
to 0.3% to 1.8% of all 
cerebrovascular complications and 
only 0.8% to 2.8% of those 
complicated by ICH. 
• The overall mortality rate = 60%. 
• Unruptured ICMAs, =30%
• Ruptured ICMAs, =80%.
*Hart et al, 1990; A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis.Peters et al,2006
**Bacterial intracranial aneurysm. J Neurosurg. 1978;48:369–382,
IE patients with cerebrovascular complications
Ischemia (N=49) 
IV 
Thrombolysis 
N=1
Thrombectomy 
N=1
Mortality 41%
Hemorrhage 
(N=22)
Mortality 45%
Arch Intern Med. 2000 Oct 9;160(18):2781-7. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Heiro M
Indication for surgery Timing Class of 
Recommendation
Level of Evidence
Valve dysfunction with heart failure Early I B
Fungi or highly resistant organisms Early I B
Heart block, annular or aortic 
abscess, or destructive penetrating 
lesions 
Early I B
Persistent infection Early I B
Recurrent emboli and persistent or 
enlarging vegetations despite 
appropriate antibiotic therapy 
Early IIa B
Severe valve regurgitation and 
mobile vegetations >10 mm
Early IIa B
Mobile vegetations >10 mm, with 
anterior leaflet of the mitral valve
Early IIb C
Early : during initial hospitalization and before 
completion of a full course of antibiotics
Circulation. 2015 Oct 13;132(15)Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals 
From the American Heart Association. Baddour LM,
Eur Heart J. 2015 Nov 21;36(44):3075-3128.2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European 
Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Habib G,
J Thorac Cardiovasc Surg. 2017 Jun;153(6):1241-1258.e29 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: 
Executive summary. AATS Surgical Treatment of Infective Endocarditis Consensus Guidelines Writing Committee Chair
J Thorac Cardiovasc Surg. 2017 Jun;153(6):1241-1258.e29 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective 
endocarditis: Executive summary. AATS Surgical Treatment of Infective Endocarditis Consensus Guidelines Writing Committee Chair




▪ Infective endocarditis is life threatening 
infection with various neurological 
complications.
▪ Stroke is the most common neurologic 
complication.
▪ Presence of vascular complication significantly 
impacts outcomes and management options.
▪ A multidisciplinary team ( Stroke Neurology, 
Infectious disease and CTS) based approach is 
essential for management of these complex 
patients.
